Food and Drug Administration GLD: Glucose-lowering drug GLP-1 RA: Glucagon-like peptide-1 receptor agonist Hb1Ac: Haemoglobin A1c HF: Heart failure HFpEF: Heart failure with preserved ejection fraction HFrEF: Heart failure with reduced ejection fraction HHF: Hospitalisation for heart failure HR: Hazard ratio KDIGO: Kidney Disease Improving Global Outcomes MACE: Major adverse cardiovascular events MI: Myocardial infarction NR: Not reported RRR: Relative risk reduction SCr: Serum creatinine SGLT2: Sodiumglucose transporter 2 T2D: Type 2 diabetes TIMI: Thrombolysis In Myocardial Infarction 3P-MACE: 3-Point major adverse cardiovascular events 4P-MACE: 4-Point major adverse cardiovascular events References Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al
The mechanism proposed: glutathione's role in reducing systemic inflammation, which otherwise triggers muscle protein breakdown during prolonged caloric deficits
A Phase 1, randomised, placebo-controlled, double-blind study was comprised of three parts: a single-ascending dose (SAD
It also provides your body with essential and non-essential amino acids to promote overall health
Strengthen Nutrition & Protein Intake This compensates for the reduced appetite control after stopping
